Exelixis Q3 2024 Adj. EPS $0.47 Beats $0.35 Estimate, Sales $539.542M Beat $490.020M Estimate
Portfolio Pulse from Benzinga Newsdesk
Exelixis reported Q3 2024 earnings per share of $0.47, surpassing the analyst estimate of $0.35 by 34.29%. The company's sales were $539.542 million, exceeding the expected $490.020 million by 10.11%, and showing a 14.33% increase from the previous year.
October 29, 2024 | 8:08 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Exelixis reported strong Q3 2024 results, with EPS and sales significantly beating analyst estimates. This performance indicates robust business growth and could positively impact the stock price.
Exelixis exceeded both EPS and sales estimates by a significant margin, indicating strong financial performance. The 14.33% YoY sales growth further supports a positive outlook. Such results typically lead to a positive market reaction, likely boosting the stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100